Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul;4(3):371-86.
doi: 10.1016/j.nurt.2007.05.006.

Iron in chronic brain disorders: imaging and neurotherapeutic implications

Affiliations
Review

Iron in chronic brain disorders: imaging and neurotherapeutic implications

James Stankiewicz et al. Neurotherapeutics. 2007 Jul.

Abstract

Iron is important for brain oxygen transport, electron transfer, neurotransmitter synthesis, and myelin production. Though iron deposition has been observed in the brain with normal aging, increased iron has also been shown in many chronic neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In vitro studies have demonstrated that excessive iron can lead to free radical production, which can promote neurotoxicity. However, the link between observed iron deposition and pathological processes underlying various diseases of the brain is not well understood. It is not known whether excessive in vivo iron directly contributes to tissue damage or is solely an epiphenomenon. In this article, we focus on the imaging of brain iron and the underlying physiology and metabolism relating to iron deposition. We conclude with a discussion of the potential implications of iron-related toxicity to neurotherapeutic development.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Gutteridge JM. Iron and oxygen radicals in brain. Ann Neurol. 1992;32:S16–S21. - PubMed
    1. Pujol J, Juque C, Vendrell P, et al. Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol. 1992;49:711–717. - PubMed
    1. Wills AJ, Sawle GV, Guilbert PR, Curtis AR. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry. 2002;73:91–92. - PMC - PubMed
    1. Riederer P, Sofic E, Rausch WD, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem. 1989;52:515–520. - PubMed
    1. Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in post-mortem parkinsonian brain. Lancet. 1987;341:1219–1220. - PubMed

Publication types